Alliancebernstein L.P. Beam Therapeutics Inc. Transaction History

Alliancebernstein L.P.

  • $290 Billion
  • Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 99,420 shares of BEAM stock, worth $2.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
99,420
Previous 86,610 14.79%
Holding current value
$2.26 Million
Previous $1.69 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$14.54 - $20.24 $186,257 - $259,274
12,810 Added 14.79%
99,420 $1.69 Million
Q1 2025

May 15, 2025
SELL
$19.53 - $34.09 $2.46 Million - $4.3 Million
-126,194 Reduced 59.3%
86,610 $1.69 Million
Q4 2024

Feb 12, 2025
BUY
$21.55 - $30.35 $2.75 Million - $3.87 Million
127,494 Added 149.45%
212,804 $5.28 Million
Q3 2024

Nov 14, 2024
SELL
$22.57 - $33.14 $63,196 - $92,792
-2,800 Reduced 3.18%
85,310 $2.09 Million
Q1 2024

May 14, 2024
BUY
$23.46 - $45.07 $91,024 - $174,871
3,880 Added 4.61%
88,110 $2.91 Million
Q4 2023

Feb 14, 2024
BUY
$17.69 - $30.76 $37,149 - $64,596
2,100 Added 2.56%
84,230 $2.29 Million
Q3 2023

Nov 14, 2023
SELL
$23.01 - $32.46 $170,274 - $240,204
-7,400 Reduced 8.27%
82,130 $1.98 Million
Q2 2023

Aug 15, 2023
BUY
$29.32 - $35.99 $569,687 - $699,285
19,430 Added 27.72%
89,530 $2.86 Million
Q3 2022

Nov 15, 2022
BUY
$39.79 - $70.31 $11,937 - $21,093
300 Added 0.43%
70,100 $3.34 Million
Q2 2022

Aug 15, 2022
BUY
$29.86 - $62.36 $394,152 - $823,152
13,200 Added 23.32%
69,800 $2.7 Million
Q1 2022

May 13, 2022
BUY
$53.73 - $82.16 $10,746 - $16,432
200 Added 0.35%
56,600 $3.24 Million
Q3 2021

Nov 10, 2021
BUY
$84.37 - $133.6 $168,740 - $267,200
2,000 Added 3.68%
56,400 $4.91 Million
Q2 2021

Jul 30, 2021
BUY
$64.12 - $128.71 $275,716 - $553,453
4,300 Added 8.58%
54,400 $7 Million
Q4 2020

Feb 08, 2021
BUY
$22.24 - $95.63 $80,064 - $344,268
3,600 Added 7.74%
50,100 $4.09 Million
Q3 2020

Nov 12, 2020
BUY
$19.0 - $30.57 $338,200 - $544,146
17,800 Added 62.02%
46,500 $1.15 Million
Q2 2020

Aug 13, 2020
BUY
$15.26 - $28.66 $268,576 - $504,416
17,600 Added 158.56%
28,700 $804,000
Q1 2020

May 14, 2020
BUY
$13.31 - $29.2 $147,741 - $324,120
11,100 New
11,100 $200,000

Others Institutions Holding BEAM

# of Institutions
249
Shares Held
95.9M
Call Options Held
666K
Put Options Held
1.99M
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.6B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email